281 related articles for article (PubMed ID: 18191104)
1. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.
Quintieri L; Palatini P; Nassi A; Ruzza P; Floreani M
Biochem Pharmacol; 2008 Mar; 75(6):1426-37. PubMed ID: 18191104
[TBL] [Abstract][Full Text] [Related]
2. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA
Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
4. Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes.
Warrington JS; Poku JW; von Moltke LL; Shader RI; Harmatz JS; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Mar; 292(3):1024-31. PubMed ID: 10688619
[TBL] [Abstract][Full Text] [Related]
5. Allosteric activation of midazolam CYP3A5 hydroxylase activity by icotinib - Enhancement by ketoconazole.
Zhuang X; Zhang T; Yue S; Wang J; Luo H; Zhang Y; Li Z; Che J; Yang H; Li H; Zhu M; Lu C
Biochem Pharmacol; 2016 Dec; 121():67-77. PubMed ID: 27666601
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of Shenmai injection, a herbal preparation, on the cytochrome P450 3A-mediated 1'-hydroxylation and 4-hydroxylation of midazolam.
Xia C; Sun J; Wang G; Shang L; Zhang X; Zhang R; Wang X; Hao H; Xie L
Chem Biol Interact; 2009 Aug; 180(3):440-8. PubMed ID: 19557931
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
[TBL] [Abstract][Full Text] [Related]
8. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
9. CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity.
Christensen H; Hestad AL; Molden E; Mathiesen L
Xenobiotica; 2011 Jan; 41(1):1-5. PubMed ID: 20954901
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-dependent metabolism of midazolam in hepatic microsomes from chickens, turkeys, pheasant and bobwhite quail.
Cortright KA; Craigmill AL
J Vet Pharmacol Ther; 2006 Dec; 29(6):469-76. PubMed ID: 17083450
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.
Patki KC; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Jul; 31(7):938-44. PubMed ID: 12814972
[TBL] [Abstract][Full Text] [Related]
12. Midazolam oxidation in cattle liver microsomes: The role of cytochrome P450 3A.
Nassi A; Quintieri L; Merlanti R; Pezzato F; Capolongo F; Pauletto M; Dacasto M; Giantin M
J Vet Pharmacol Ther; 2020 Nov; 43(6):608-613. PubMed ID: 32893906
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effect of Oxethazaine on Midazolam Metabolism in Rats.
Namba H; Nishimura Y; Kurata N; Iwase M; Hirai T; Kiuchi Y
Biol Pharm Bull; 2017; 40(9):1361-1365. PubMed ID: 28867721
[TBL] [Abstract][Full Text] [Related]
14. Evidence of CYP3A allosterism in vivo: analysis of interaction between fluconazole and midazolam.
Yang J; Atkins WM; Isoherranen N; Paine MF; Thummel KE
Clin Pharmacol Ther; 2012 Mar; 91(3):442-9. PubMed ID: 22048224
[TBL] [Abstract][Full Text] [Related]
15. Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions.
Blobaum AL; Bridges TM; Byers FW; Turlington ML; Mattmann ME; Morrison RD; Mackie C; Lavreysen H; Bartolomé JM; Macdonald GJ; Steckler T; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Stauffer SR; Daniels JS
Drug Metab Dispos; 2013 Dec; 41(12):2066-75. PubMed ID: 24003250
[TBL] [Abstract][Full Text] [Related]
16. Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine, and testosterone.
Miyazaki M; Nakamura K; Fujita Y; Guengerich FP; Horiuchi R; Yamamoto K
Drug Metab Dispos; 2008 Nov; 36(11):2287-91. PubMed ID: 18669585
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Action of Panaxytriol on Midazolam 1'-Hydroxylation and 4-Hydroxylation Mediated by CYP3A in Liver Microsomes and Rat Primary Hepatocytes.
He F; Zhang W; Zeng C; Xia C; Xiong Y; Zhang H; Huang S; Liu M
Biol Pharm Bull; 2015; 38(10):1470-7. PubMed ID: 26424012
[TBL] [Abstract][Full Text] [Related]
18. Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro.
Oda Y; Mizutani K; Hase I; Nakamoto T; Hamaoka N; Asada A
Br J Anaesth; 1999 Jun; 82(6):900-3. PubMed ID: 10562786
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo glucuronidation of midazolam in humans.
Hyland R; Osborne T; Payne A; Kempshall S; Logan YR; Ezzeddine K; Jones B
Br J Clin Pharmacol; 2009 Apr; 67(4):445-54. PubMed ID: 19371318
[TBL] [Abstract][Full Text] [Related]
20. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
